These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

409 related articles for article (PubMed ID: 21996283)

  • 21. Prebiotics and probiotics: their role in the management of gastrointestinal disorders in adults.
    Quigley EM
    Nutr Clin Pract; 2012 Apr; 27(2):195-200. PubMed ID: 22127952
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inflammatory bowel disease, gut bacteria and probiotic therapy.
    Reiff C; Kelly D
    Int J Med Microbiol; 2010 Jan; 300(1):25-33. PubMed ID: 19800289
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Probiotics and mucosal barrier in children.
    Penna FJ; Péret LA; Vieira LQ; Nicoli JR
    Curr Opin Clin Nutr Metab Care; 2008 Sep; 11(5):640-4. PubMed ID: 18685462
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Gut flora in health and disease: potential role of probiotics.
    Heselmans M; Reid G; Akkermans LM; Savelkoul H; Timmerman H; Rombouts FM
    Curr Issues Intest Microbiol; 2005 Mar; 6(1):1-7. PubMed ID: 15751747
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The normal intestinal microbiota.
    Marchesi J; Shanahan F
    Curr Opin Infect Dis; 2007 Oct; 20(5):508-13. PubMed ID: 17762785
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Bacteria in the pathogenesis of inflammatory bowel disease.
    Subramanian S; Campbell BJ; Rhodes JM
    Curr Opin Infect Dis; 2006 Oct; 19(5):475-84. PubMed ID: 16940872
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The microbiome and inflammatory bowel disease: is there a therapeutic role for fecal microbiota transplantation?
    Damman CJ; Miller SI; Surawicz CM; Zisman TL
    Am J Gastroenterol; 2012 Oct; 107(10):1452-9. PubMed ID: 23034604
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The microbiome-gut-brain axis: from bowel to behavior.
    Cryan JF; O'Mahony SM
    Neurogastroenterol Motil; 2011 Mar; 23(3):187-92. PubMed ID: 21303428
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The use of probiotics in IBD and IBS.
    De Greef E; Vandenplas Y; Hauser B; Devreker T; Veereman G
    Minerva Pediatr; 2014 Oct; 66(5):491-500. PubMed ID: 25243502
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Probiotics: history, definition, requirements and possible therapeutic applications].
    Montalto M; Arancio F; Izzi D; Cuoco L; Curigliano V; Manna R; Gasbarrini G
    Ann Ital Med Int; 2002; 17(3):157-65. PubMed ID: 12402663
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Gut microbiota and IBD].
    Seksik P
    Gastroenterol Clin Biol; 2010 Sep; 34 Suppl 1():S44-51. PubMed ID: 20889004
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Probiotics, gut microbiota and health.
    Butel MJ
    Med Mal Infect; 2014 Jan; 44(1):1-8. PubMed ID: 24290962
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Alterations in intestinal microbial flora and human disease.
    Othman M; Agüero R; Lin HC
    Curr Opin Gastroenterol; 2008 Jan; 24(1):11-6. PubMed ID: 18043226
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Interactions between commensal bacteria and gut sensorimotor function in health and disease.
    Barbara G; Stanghellini V; Brandi G; Cremon C; Di Nardo G; De Giorgio R; Corinaldesi R
    Am J Gastroenterol; 2005 Nov; 100(11):2560-8. PubMed ID: 16279914
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Irritable bowel syndrome, inflammatory bowel disease and the microbiome.
    Major G; Spiller R
    Curr Opin Endocrinol Diabetes Obes; 2014 Feb; 21(1):15-21. PubMed ID: 24296462
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Role of intestinal flora in inflammatory bowel disease and probiotics place in their management].
    Belkahla N; Maamouri N; Ouerghi H; Ben Ammar A
    Tunis Med; 2005 Mar; 83(3):132-6. PubMed ID: 15929439
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prebiotics in inflammatory bowel diseases.
    Guarner F
    Br J Nutr; 2007 Oct; 98 Suppl 1():S85-9. PubMed ID: 17922967
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Bacterial flora as a cause or treatment of chronic diarrhea.
    Scaldaferri F; Pizzoferrato M; Pecere S; Forte F; Gasbarrini A
    Gastroenterol Clin North Am; 2012 Sep; 41(3):581-602. PubMed ID: 22917165
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inflammatory bowel disease: current insights into pathogenesis and new therapeutic options; probiotics, prebiotics and synbiotics.
    Geier MS; Butler RN; Howarth GS
    Int J Food Microbiol; 2007 Apr; 115(1):1-11. PubMed ID: 17137666
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Quantitative Risk-Benefit Analysis of Probiotic Use for Irritable Bowel Syndrome and Inflammatory Bowel Disease.
    Bennett WE
    Drug Saf; 2016 Apr; 39(4):295-305. PubMed ID: 26467550
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.